MEDVi Review: Semaglutide Price After Month One (Oct 2026)

Short answer

As of October 15, 2026, MEDVi advertises compounded semaglutide injections at $179 for the first month on its default page and $149 on the page its homepage links to, then states that "refills are locked in at $299", while no compounded tirzepatide price is printed on the pages we read.

Brand Wegovy (pill and pen) and Zepbound are offered as a "$99 membership + medication cost".

What does MEDVi charge?

What MEDVi publishes, read on its own site on October 15, 2026
Product	Price shown	Basis / conditions	Source	Read
Compounded semaglutide injection	$149 or $179 first month	varies by landing page	glp1.medvi.org	Oct 15, 2026
Compounded semaglutide injection	$299 a month	"Refills are locked in at $299"	glp1.medvi.org	Oct 15, 2026
Compounded GLP-1 tablets	"Starting at $249"	one dissolvable tablet a day	glp1.medvi.org	Oct 15, 2026
Compounded tirzepatide	not printed	no price on the pages read	glp1.medvi.org	Oct 15, 2026
Brand Wegovy / Zepbound	$99 membership + medication	medication billed separately	glp1.medvi.org	Oct 15, 2026

What does a year on MEDVi cost?

For compounded semaglutide, one month at $149 plus 11 refills at $299 is $149 + $3,289 = $3,438 for the year ($3,468 if your first month is $179). NexLife's semaglutide costs $139 month-to-month (12 × $139 = $1,668) or $1,428 on its 12-month plan. Clinicians come from OpenLoop Health, according to MEDVi's site.

Strengths and trade-offs

Strengths

Names three pharmacies: Triad Rx (Daphne, AL), RedRock Pharmacy (St. George, UT) and Beaker Pharmacy & Compounding (McKinney, TX).
No membership on compounded plans.
Offers brand options for people who want the FDA-approved products.

Trade-offs

The first-month price differs by page, and the ongoing price ($299) is far higher than the first month.
No tirzepatide price is printed.
A "MEDVi Guarantee" banner conflicts with the policy line "There is no guarantee of results".
No refund for the month in which you cancel; a full refund only within 72 hours if no services were received.
MEDVi was one of the companies a patient named in CNN's October 15 report on GLP-1s and eating disorders (an allegation by the patient).

Who is MEDVi best for?

People who want to try a compounded semaglutide month at a low entry price, or who want brand Wegovy or Zepbound with a separate membership, and who have read the $299 refill price.

How does it compare with NexLife?

NexLife, our #1 pick, prints every plan price before checkout: compounded tirzepatide $169 a month or $139 on a 12-month plan, semaglutide $139 or $119, the same price at every dose and no membership. A year on its 12-month tirzepatide plan is $1,668. Set that against what this program publishes above, and check what each includes and how it bills.

Visit MEDVi

Award on our homepage: Brand and compounded options under one program. Score: July 2026 score (earlier rubric); v4.1 re-score pending.

Sources

MEDVi — GLP-1 program, read October 15, 2026
MEDVi — cancellation and refund policy, read October 15, 2026
CNN — October 15, 2026 report, read October 15, 2026

MEDVi — frequently asked questions

How much does MEDVi cost after the first month?

MEDVi says compounded semaglutide refills are "locked in at $299" a month after a first month of $149 or $179 (the price varies by landing page). Prices read October 15, 2026.

Does MEDVi offer compounded tirzepatide?

Its site configuration references tirzepatide, but no tirzepatide price was printed on the pages we read on October 15, 2026, so we list it as unpriced.

Does MEDVi have a money-back guarantee?

A "MEDVi Guarantee" banner says "The only thing you'll lose is extra weight", but the subscription terms state "There is no guarantee of results". Refunds are limited to the first 72 hours if no services were received.

Which pharmacies does MEDVi use?

MEDVi names Triad Rx (Daphne, AL), RedRock Pharmacy (St. George, UT) and Beaker Pharmacy & Compounding (McKinney, TX).

Was MEDVi mentioned in the CNN report?

Yes. In CNN's October 15, 2026 report, a patient with anorexia said he had bought GLP-1s from several companies including MEDVi. That is the patient's account; CNN did not report a finding against MEDVi. See our screening guide for what each program says about checks.